Use of PET/MR Imaging in Chronic Pain
Trial ID or NCT#
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Use of [18F]FDG PET/MRI in the Diagnosis of Pain Generators and/or Sites of Inflammation and to Monitor Treatment Effects in Patients With Chronic Pain
- - Age 18 years or older. - Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica, complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy, osteoarthritis, cancer pain, persistent post-operative pain, and migraine. - Provides informed consent - On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale - Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
- - MRI-incompatible - Diabetes - Pregnant or nursing - Non-English speaker - Claustrophobic
Contact us to find out if this trial is right for you.
Sunyoung Park, BA